ARTICLE | Company News
Cognetix other research news
February 12, 2001 8:00 AM UTC
Cognetix received a $100,000 Phase I SBIR grant from the National Institute of Allergy and Infectious Diseases to develop a conopeptide that modulates potassium channels involved in airway orders, for...